GLP1R Small Molecule Agonists Could Make a Meaningful Difference for Patients

Time: 2:00 pm
day: Conference Day Two


  • Examining the need for differentiated products as more GLP-1s are being developed
  • Developing small molecule GLP1R agonists to meet the specific needs of the patients
  • Exploring the opportunities for combinations of agonists to gain long-term health benefits